6 pending office actions • 4 art units • 5 examiners • 0 of 6 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 6 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 6 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 2 (33%) |
| §102 only | 1 (17%) |
| No statute on record | 3 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| HADDAD, MAHER M | 2 | 50.4% | +54.3% |
| WHITE, DAWANNA SHAR-DAY | 1 | 62.3% | +24.5% |
| PACKARD, BENJAMIN J | 1 | 66.2% | +15.8% |
| SHARMA, YASHITA | 1 | 82.2% | +26.2% |
| PETERS, ALEC JON | 1 | 68.6% | +61.7% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17906438 | DEVICES AND METHODS FOR TREATING A FISTULA | SHARMA, YASHITA | 35d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 6 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18731923 | ADMINISTRATION OF AURORA KINASE INHIBITOR AND CHEMOTHERAPEUTIC AGENTS | WHITE, DAWANNA SHAR-DAY | 98d overdue |
| 16608895 | METHOD OF TREATING PEDIATRIC DISORDERS | HADDAD, MAHER M | 84d overdue |
| 17655541 | METHODS FOR THE TREATMENT OF CHRONIC POUCHITIS | HADDAD, MAHER M | 67d overdue |
| 17604324 | ALPHA4BETA7 INHIBITOR AND IL-23 INHIBITOR COMBINATION THERAPY | PETERS, ALEC JON | 38d overdue |
| 17906438 | DEVICES AND METHODS FOR TREATING A FISTULA | SHARMA, YASHITA | 35d overdue |
| 17919952 | LIPID COMPOSITIONS FOR DELIVERY OF STING AGONIST COMPOUNDS AND USES THEREOF | PACKARD, BENJAMIN J | 28d overdue |
| Art Unit | Apps |
|---|---|
| 1641 | 3 |
| 1627 | 1 |
| 1612 | 1 |
| 3774 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18731923 | ADMINISTRATION OF AURORA KINASE INHIBITOR AND CHEMOTHERAPEUTIC AGENTS | WHITE, DAWANNA SHAR-DAY | 1627 | Other | Non-Final OA | 98d overdue | Pending | Jun 03, 2024 |
| 17919952 | LIPID COMPOSITIONS FOR DELIVERY OF STING AGONIST COMPOUNDS AND USES THEREOF | PACKARD, BENJAMIN J | 1612 | Other | Non-Final OA | 28d overdue | Pending | Oct 19, 2022 |
| 17906438 | DEVICES AND METHODS FOR TREATING A FISTULA | SHARMA, YASHITA | 3774 | §103 | Final Rejection | 35d overdue | Pending | Sep 15, 2022 |
| 17655541 | METHODS FOR THE TREATMENT OF CHRONIC POUCHITIS | HADDAD, MAHER M | 1641 | §102 | Non-Final OA | 67d overdue | Pending | Mar 18, 2022 |
| 17604324 | ALPHA4BETA7 INHIBITOR AND IL-23 INHIBITOR COMBINATION THERAPY | PETERS, ALEC JON | 1641 | Other | Final Rejection | 38d overdue | Pending | Oct 15, 2021 |
| 16608895 | METHOD OF TREATING PEDIATRIC DISORDERS | HADDAD, MAHER M | 1641 | §103 | Non-Final OA | 84d overdue | Pending | Oct 28, 2019 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial